While IL6 is traditionally considered pro-tumorigenic, its elevation in this study may reflect immune activation, possibly enhancing myeloid cell-mediated tumor surveillance or counteracting T-cell exhaustion, as indicated by scRNA-seq localization of IL6 in myeloid compartments. Here, IL6 is linked to neoplasm.